Prognosis of Castration-resistant Prostate Cancer Patients - Use of the AdnaTest® System for Detection of Circulating Tumor Cells. [electronic resource]
Producer: 20160830Description: 2019-26 p. digitalISSN:- 1791-7530
- Aged
- Aged, 80 and over
- Antineoplastic Agents -- therapeutic use
- Docetaxel
- Humans
- Kaplan-Meier Estimate
- Male
- Middle Aged
- Neoplastic Cells, Circulating
- Prognosis
- Prostate-Specific Antigen -- blood
- Prostatic Neoplasms, Castration-Resistant -- blood
- Reverse Transcriptase Polymerase Chain Reaction
- Taxoids -- therapeutic use
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.